Related references
Note: Only part of the references are listed.Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice
Philip E. Lapinski et al.
DISEASE MODELS & MECHANISMS (2013)
Structural and Mechanistic Insights into LEOPARD Syndrome-Associated SHP2 Mutations
Zhi-Hong Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature
Audrey De Rocca Serra-Nedelec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis
Emilie A. Bard-Chapeau et al.
CANCER CELL (2011)
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations
Timothy J. Bauler et al.
DISEASE MODELS & MECHANISMS (2011)
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation
Talita M. Marin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phosphatase-Dependent and -Independent Functions of Shp2 in Neural Crest Cells Underlie LEOPARD Syndrome Pathogenesis
Rodney A. Stewart et al.
DEVELOPMENTAL CELL (2010)
Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3β Signaling
Thomas Edouard et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Identification and Expression of the Family of Classical Protein-Tyrosine Phosphatases in Zebrafish
Mark van Eekelen et al.
PLOS ONE (2010)
Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis
M. Tartaglia et al.
MOLECULAR SYNDROMOLOGY (2010)
Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development
Kimihiko Oishi et al.
HUMAN MOLECULAR GENETICS (2009)
Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development
Tomoki Nakamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations
Tomoki Nakamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
Marie Dance et al.
CELLULAR SIGNALLING (2008)
Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal -: Regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways
Maria I. Kontaridis et al.
CIRCULATION (2008)
Shp2 knockdown and Noonan/LEOPARD mutant Shp2-induced gastrulation defects
Chris Jopling et al.
PLOS GENETICS (2007)
Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality
Yuehai Ke et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Animal models of human disease: zebrafish swim into view
Graham J. Lieschke et al.
NATURE REVIEWS GENETICS (2007)
Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection
Emilie A. Bard-Chapeau et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1
Nadine Hanna et al.
FEBS LETTERS (2006)
PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects
MI Kontaridis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome
P Rodriguez-Viciana et al.
SCIENCE (2006)
An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival
WT Yang et al.
DEVELOPMENTAL CELL (2006)
Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations
K Oishi et al.
HUMAN MOLECULAR GENETICS (2006)
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Diverse biochemical properties of Shp2 mutants
H Keilhack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Major events in the genome evolution of vertebrates: Paranome age and size differ considerably between ray-finned fishes and land vertebrates
K Vandepoele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
T Araki et al.
NATURE MEDICINE (2004)
Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype
O Jaillon et al.
NATURE (2004)
Adult height in Noonan syndrome
JA Noonan et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
BG Neel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Efficient target-selected mutagenesis in zebrafish
E Wienholds et al.
GENOME RESEARCH (2003)
Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene
MC Digilio et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
PTPN11 mutations in Noonan syndrome:: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
M Tartaglia et al.
NATURE GENETICS (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
